UM Cancer researchers test custom-made vaccine for non-Hodgkin's lymphoma

As part of a national multi-center study, researchers at the University of Maryland Greenebaum Cancer Center in Baltimore are testing a custom-made vaccine for low-grade non-Hodgkins lymphoma that uses each patients own tumor cells to combat the cancer.

This type of low-grade follicular lymphoma has traditionally been highly treatable, but essentially incurable, says Aaron P. Rapoport, M.D., the director of lymphoma-gene medicine at the Greenebaum Cancer Center and the chief investigator for the study. This technique for harnessing the immune system may result in long-term disease remission and potential cures for some patients.

So far, four people have been enrolled in the study at the Greenebaum Cancer Center, but researchers hope to recruit a total of 12 to 15 patients in the Phase III clinical trial. The first patient to be vaccinated, a 45-year-old Baltimore woman, started her treatment earlier this month after completing a course of chemotherapy.

About 480 patients are expected to participate in the nationwide study at 25 institutions in the United States and Canada. The study is sponsored by Genitope Corporation, a California-based biotechnology company developing new therapies for treating cancer.

To be eligible for the study, patients must have been diagnosed with follicular lymphoma, a common form of cancer of the lymphatic system, and have not yet received treatment. If enrolled, they will have a small biopsy taken of their cancer, either from a lymph node or bone marrow, which will be sent to Genitope Corporation to make a vaccine unique to each patient.

The customized vaccine is designed to target a tumor-specific marker, or idiotype, which, like a fingerprint, is unique to every lymphoma patient. Once injected, the vaccine is intended to activate the immune system to attack cells that have the idiotype protein on their surface, namely the cancer cells.


Contact: Karen E. Warmkessel
University of Maryland Medical Center

Page: 1 2 3

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Cancer gene MYC emerging as key research target
5. Cancer patient, heal thyself
6. USC researcher named General Motors Cancer Research Scholar
7. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
8. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
9. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
10. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
11. National Cancer Gene Therapy Foundation gives $4.0 million in research grants

Post Your Comments:

(Date:12/13/2018)... ... December 13, 2018 , ... Biocompare, the ... entitled “What Researchers Need to Know about Antibody Manufacturing” . This educational ... series. The goal of this film is to educate scientists about antibody production, ...
(Date:12/5/2018)... ... December 05, 2018 , ... Dr. Nicolas ... symposium 2018, London, England. The 2018 PDT symposium was organized by the RSM ... its benefits in clinical practice across a range of applications in oncology and ...
(Date:12/5/2018)... ... December 04, 2018 , ... Lifecycle Biotechnologies, a leading life ... (26 gallon) SAFEthread Drum. The 100-liter SAFEthread Drum follows the launch of ... modern redesign to the plastic drums being used globally. Manufactured at Lifecycle’s ...
Breaking Biology News(10 mins):
(Date:12/10/2018)... Shandong, China and SAN DIEGO (PRWEB) , ... ... ... MabPlex International, Ltd., a fully integrated Contract Development and Manufacturing Organization ... line) development, process characterization, conjugation optimization, cGMP manufacturing, and aseptic fill finish ...
(Date:12/5/2018)... ... ... STRmix™ – sophisticated forensic software capable of resolving mixed DNA profiles previously thought ... man of third-degree sexual assault, a felony punishable by imprisonment for up to 15 ... couch cushions on which the sexual assault was alleged to have taken place. , ...
(Date:11/28/2018)... ... 2018 , ... Earlier this month, Lajollacooks4u's Founder and Chef Jodi Abel traveled ... of truffle season. , Her first stop was Umbria, a region in ... Black Truffle Lodge in the small mountain village of Pettino, Chef Jodi was introduced ...
(Date:11/20/2018)... ... November 19, 2018 , ... The International Society for Biological ... translation of Best Practices: Recommendations for Repositories, Fourth Edition. , The Fourth Edition ... the science of biobanking to meet the needs of a growing industry. The ...
Breaking Biology Technology:
Cached News: